Glenview Trust’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
18,200
-1,325
-7% -$24.7K ﹤0.01% 425
2026
Q1
$352K Sell
19,525
-5,530
-22% -$107K 0.01% 414
2025
Q4
$507K Sell
25,055
-3,967
-14% -$80K 0.01% 367
2025
Q3
$592K Buy
29,022
+5,822
+25% +$129K 0.01% 354
2025
Q2
$509K Buy
+23,200
New +$493K 0.01% 372
2025
Q1
Sell
-32,500
Closed -$711K 476
2024
Q4
$711K Sell
32,500
-5,137
-14% -$111K 0.01% 309
2024
Q3
$788K Sell
37,637
-2,000
-5% -$41.5K 0.02% 293
2024
Q2
$826K Buy
39,637
+2,000
+5% +$41.8K 0.02% 274
2024
Q1
$784K Buy
37,637
+2,000
+6% +$40.5K 0.02% 283
2023
Q4
$714K Buy
35,637
+8,225
+30% +$160K 0.02% 289
2023
Q3
$534K Buy
+27,412
New +$531K 0.01% 306

Other funds holding ARCC

Glenview Trust's ARCC Position: Q2 2026 in Review

Glenview Trust reduced its Ares Capital (ARCC) stake by 6.8% in Q2 2026, selling an estimated $24.7K and leaving 18,200 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Glenview Trust first reported a position in ARCC in Q3 2023 and has held it in 11 quarters since. The position peaked at $826K in Q2 2024. 784 funds tracked by Wall St. Rank hold ARCC as of Q2 2026.

  • Glenview Trust held 18,200 shares of Ares Capital worth $337K as of Q2 2026.
  • Glenview Trust sold 1,325 Ares Capital shares in Q2 2026, an estimated $24.7K.
  • Ares Capital made up ﹤0.01% of Glenview Trust's portfolio in Q2 2026, its #425 holding.
  • Glenview Trust first reported a position in Ares Capital in Q3 2023 and has held it in 11 quarters since.
  • Glenview Trust's Ares Capital position peaked at $826K in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Ares Capital as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.